[1] Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults [J]. Lancet Neurol, 2008, 7(8): 728-741. [2] Andriessen TM, Horn J, Franschman G, et al. Epidemiology, severity classification, and outcome of moderate and severe traumatic brain injury: a prospective multicenter study [J]. J Neurotrauma, 2011, 28(10): 2019-2031. [3] Georgio Poulos M, Katsakiori P, Kefalopoulou Z, et al. Vegetative state and minimally conscious state: a review of the therapeutic interventions [J]. Stereotact Funct Neurosurg, 2010, 88(4): 199-207. [4] Neren D, Johnson MD, Legon W, et al. Vagus nerve stimulation and other neuromodulation methods for treatment of traumatic brain injury [J]. Neurocrit Care, 2016, 24(2): 308-319. [5] Kumaria A, Tolias CM. Is there a role for vagus nerve stimulation therapy as a treatment of traumatic brain injury? [J]. Br J Neurosurg, 2012, 26(3): 316-320. [6] Shi C, Flanagan SR, Samadani U. Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial [J]. Neurol Res, 2013, 35(3): 263-276. [7] 宋璐,刘爱华. 迷走神经刺激术在非癫痫领域的应用进展[J]. 中华临床医师杂志(电子版), 2012, 6(17): 5191-5194. [8] Gmeiner F, Kołodziejczyk A, Yoshii T, et al. GABA(B) receptors play an essential role in maintaining sleep during the second half of the night in Drosophila melanogaster [J]. J Exp Biol, 2013, 216(Pt 20): 3837-3843. [9] Vienne J, Bettler B, Franken P, et al. Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric acid, and Baclofen on EEG activity and sleep regulation [J]. J Neurosci, 2010, 30(42): 14194-14204. [10] de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions [J]. Front Pharmacol, 2014, 5: 16. [11] Feng Z, Zhong YJ, Wang L, et al. Resuscitation therapy for traumatic brain injury-induced coma in rats: mechanisms of median nerve electrical stimulation [J]. Neural Regen Res, 2015, 10(4): 594-598. [12] Feng Z, Du Q. Mechanisms responsible for the effect of median nerve electrical stimulation on traumatic brain injury induced coma: orexin-A-mediated N-methyl-Daspartate receptor subunit NR1 upregulation [J]. Neural Regen Res, 2016, 11(6): 951-956. [13] Jiang Y, Li L, Liu B, et al. PPARγ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats [J]. Med Sci Monit, 2015, 21: 268-275. [14] 陶玉,尹海兵,陈旭东,等. UBE2C基因在食管鳞癌中的表达及其临床意义[J]. 江苏医药, 2016, 42(16): 1816-1818. [15] Zhou L, Lin J, Kui G, et al. Neuroprotective effects of vagus nerve stimulation on traumatic brain injury [J]. Neural Regen Res, 2014, 9(17): 1585-1591. [16] Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects [J]. Neurosci Biobehav Rev, 2005, 29(3): 493-500. [17] Vonck K, Raedt R, Naulaerts J, et al. Vagus nerve stimulation…25 years later! What do we know about the effects on cognition? [J]. Neurosci Biobehav Rev, 2014, 45: 63-71. [18] Hays SA. Enhancing rehabilitative therapies with vagus nerve stimulation [J]. Neurotherapeutics, 2016, 13(2): 382-394. [19] Smith DC, Tan AA, Duke A, et al. Recovery of function after vagus nerve stimulation initiated 24 hours after fluid percussion brain injury [J]. J Neurotrauma, 2006, 23(10): 1549-1560. [20] Pruitt DT, Schmid AN, Kim LJ, et al. Vagus nerve stimulation delivered with motor training enhances recovery of function after traumatic brain injury [J]. J Neurotrauma, 2016, 33(9): 871-879. [21] Clough RW, Neese SL, Sherill LK, et al. Cortical edema in moderate fluid percussion brain injury is attenuated by vagus nerve stimulation [J]. Neuroscience, 2007, 147(2): 286-293. [22] Lopez NE, Krzyzaniak MJ, Costantini TW, et al. Vagal nerve stimulation decreases blood-brain barrier disruption after traumatic brain injury [J]. J Trauma Acute Care Surg, 2012, 72(6): 1562-1566. [23] Bansal V, Ryu SY, Lopez N. Vagal stimulation modulates inflammation through a ghrelin mediated mechanism in traumatic brain injury [J]. Inflammation, 2012, 35(1): 214-220. [24] Labiner DM, Ahern GL. Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings [J]. Acta Neurol Scand, 2007, 115(1): 23-33. [25] 董晓阳,冯珍. 迷走神经电刺激对脑外伤昏迷大鼠前额叶皮质5-羟色胺2A受体表达的影响[J]. 中国康复理论与实践, 2016, 22(4): 404-408. [26] Ansari S, Chaudhri K, AlMoutaery KA. Vagus nerve stimulation: indications and limitations [J]. Acta Neurochir Suppl, 2007, 97(2): 281-286. [27] Ruffoli R, Giorgi FS, Pizzanelli C, et al. The chemical neuroanatomy of vagus nerve stimulation [J]. J Chem Neuroanat, 2011, 42(4): 288-296. [28] Benke D, Zemoura K, Maier PJ. Modulation of cell surface GABAB receptors by desensitization, trafficking and regulated degradation [J]. World J Biol Chem, 2012, 3(4): 61-72. [29] 袁莲芳,陈果,侯丽,等. γ-氨基丁酸B受体与应激性防御反应研究现状[J]. 中华实用诊断与治疗杂志, 2015, 29(6): 521-523. [30] Black SW, Morairty SR, Chen TM, et al. GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy [J]. J Neurosci, 2014, 34(19): 6485-6494. |